Applied Therapeutics (APLT) Treasury Shares (2023 - 2025)
Historic Treasury Shares for Applied Therapeutics (APLT) over the last 3 years, with Q3 2025 value amounting to $4.8 million.
- Applied Therapeutics' Treasury Shares fell 2215.43% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 2215.43%. This contributed to the annual value of $3.7 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Applied Therapeutics' Treasury Shares is $4.8 million, which was down 2215.43% from $5.0 million recorded in Q2 2025.
- Applied Therapeutics' Treasury Shares' 5-year high stood at $6.5 million during Q1 2024, with a 5-year trough of $3.3 million in Q1 2023.
- Its 3-year average for Treasury Shares is $4.8 million, with a median of $4.9 million in 2025.
- As far as peak fluctuations go, Applied Therapeutics' Treasury Shares skyrocketed by 10060.92% in 2024, and later plummeted by 2215.43% in 2025.
- Quarter analysis of 3 years shows Applied Therapeutics' Treasury Shares stood at $3.3 million in 2023, then grew by 11.69% to $3.7 million in 2024, then surged by 30.02% to $4.8 million in 2025.
- Its Treasury Shares was $4.8 million in Q3 2025, compared to $5.0 million in Q2 2025 and $5.1 million in Q1 2025.